Skip to content

Upstream Bio, Inc. UPB Operating margin

Operating margin at other companies

Amgen logo
AmgenAMGN
28.4%+6.6pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
24.3%-2.9pp
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-961.9%+259pp
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-5,266.4%-9,520pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
17.6%+9.6pp
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-15,536.1%-17,275pp

Other financials

Income statement

See full
Revenue$1.0M+82.7%
Operating income-$43.6M-36.2%
Net income-$40.6M-48.8%
EPS (diluted)-$0.75-47.1%

Balance sheet

See full
Cash & equivalents$96.7M+35.6%
Total debt$1.1M-34.5%
Total equity$304.0M-31.8%
Total assets$318.1M-30.3%

Cash flow

See full
Operating cash flow-$47.9M-16.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$346.11M-40.9%
Enterprise value$250.5M-51.4%
P/S104.2×-151×

Profitability

See full
Net margin-4,719%+2,752pp

Returns & leverage

See full
Return on equity-41.8%
Debt / equity0.0×
Current ratio23.1×-24.3×

Where this comes from

Calculated from Upstream Bio, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Upstream Bio, Inc.'s operating margin?
Upstream Bio, Inc. (UPB) reported operating margin of -5,176.5% in Q1 2026.
How has Upstream Bio, Inc.'s operating margin changed year-over-year?
Upstream Bio, Inc.'s operating margin decreased by 25.4% year-over-year, from -4,127.4% to -5,176.5%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.